Vera Therapeutics said the U.S. Food and Drug Administration granted accelerated approval for Trutakna to reduce proteinuria, or protein in urine, for adults with primary IgA nephropathy who are at ...
Shares of Cognizant Technology Solutions rose after the company expanded its partnership with Alphabet's Google, allowing Cognizant to bring artificial intelligence to more customers and deepening its ...
The U.S. Energy Information Administration lowered its oil price estimates for this year and next as the resumption of oil shipments out of the Persian Gulf under the U.S.-Iran agreement leads to a ...
The PHLX Semiconductor Index was dropping 4.8% in recent trading, to 12,280, to put it on track for its first close below the ...
Crude oil contracts rose by more than $1 around midday Tuesday after a new round of attacks by Iran on oil tankers near the Strait of Hormuz, while further gains were limited due to lingering worries ...
Airbus and MTU Aero Engines are teaming up to form a joint venture to develop and commercialize a fully electric hydrogen fuel cell engine. Airbus said Tuesday the planned collaboration aims to speed ...
Airbus secured a contract to deliver 10 H125 helicopters to the aviation wing of U.S. border enforcement, which will be deployed for law enforcement operations across the country. The aerospace ...
Shares of SkinHealth Systems rose as the medical aesthetics company said it received new FDA clearance for its SkinStylus microneedling device. The stock was up 39% to $1.05 in recent trading, but ...
Financial experts on what to do — and what not to do — if you started saving late and haven’t saved enough for retirement ...
Raytheon and a coalition of North Atlantic Treaty Organization allies signed an agreement to expand the AMRAAM missile program, clearing the way to build components of the advanced air-to-air missile ...
Shares of AmpliTech Group are continuing this year's hot streak after the company said it would buy back up to $10 million in stock and end its at-the-market equity offering. The stock was up 5.7% at ...
1h
Agios Pharmaceuticals Shares Rise After FDA Grants Priority Review for Sickle Cell Disease Treatment
Agios Pharmaceuticals shares rose Tuesday after the U.S. Food and Drug Administration granted priority review to the company's supplemental new drug application for mitapivat to treat sickle cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results